We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MSFT icon
Microsoft
MSFT
+$205M
3
TSLA icon
Tesla
TSLA
+$83.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$65.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$64.9M

Top Sells

Rank Stock Value
1
SQM icon
Sociedad Química y Minera de Chile
SQM
+$60.4M
2
META icon
Meta Platforms (Facebook)
META
+$39.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$36.9M
4
BKNG icon
Booking.com
BKNG
+$28M
5
SYK icon
Stryker
SYK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
351
Parker-Hannifin
PH
$120B
$5.74M 0.04%
23,677
+10,164
+75% +$2.75M
SLB icon
352
SLB Ltd
SLB
$72.7B
$5.73M 0.04%
159,500
-10,217
-6% -$370K
KMB icon
353
Kimberly-Clark
KMB
$37.6B
$5.65M 0.04%
50,206
+25,788
+106% +$3.35M
IMCR icon
354
Immunocore
IMCR
$1.7B
$5.6M 0.04%
+119,322
New +$5.69M
MCK icon
355
McKesson
MCK
$104B
$5.57M 0.04%
16,379
-1,913
-10% -$664K
BLK icon
356
Blackrock
BLK
$167B
$5.5M 0.04%
10,001
-150
-1% -$98.2K
PCAR icon
357
PACCAR
PCAR
$70.5B
$5.5M 0.04%
98,618
-3,976
-4% -$231K
EVA
358
DELISTED
Enviva Inc.
EVA
$5.46M 0.04%
90,871
+13,191
+17% +$887K
EQR icon
359
Equity Residential
EQR
$25.8B
$5.36M 0.04%
79,765
+31,886
+67% +$2.36M
FHN icon
360
First Horizon
FHN
$12.2B
$5.33M 0.04%
232,795
– –
RXDX
361
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$5.31M 0.04%
+90,000
New +$4.12M
DYN icon
362
Dyne Therapeutics
DYN
$4.68B
$5.25M 0.04%
413,624
– –
ENTA icon
363
Enanta Pharmaceuticals
ENTA
$362M
$5.21M 0.04%
100,507
-14,000
-12% -$818K
GOSS icon
364
Gossamer Bio
GOSS
$101M
$5.21M 0.04%
+434,452
New +$5.39M
VTR icon
365
Ventas
VTR
$47.5B
$5.2M 0.04%
129,497
+91,806
+244% +$4.51M
ROP icon
366
Roper Technologies
ROP
$40.4B
$5.19M 0.04%
14,419
+8,019
+125% +$3.26M
INBX
367
DELISTED
Inhibrx, Inc. Common Stock
INBX
$5.15M 0.04%
287,069
-65,000
-18% -$1.17M
PLNT icon
368
Planet Fitness
PLNT
$4.45B
$5.15M 0.04%
89,348
+11,977
+15% +$863K
VLO icon
369
Valero Energy
VLO
$89.5B
$5.14M 0.04%
48,145
+8,675
+22% +$955K
CDW icon
370
CDW
CDW
$18.9B
$5.14M 0.04%
32,909
+12,598
+62% +$2.16M
IDXX icon
371
Idexx Laboratories
IDXX
$44.9B
$5.13M 0.04%
15,757
+9,622
+157% +$3.53M
DELL icon
372
Dell
DELL
$239B
$5.13M 0.04%
150,011
+20,105
+15% +$846K
BNY
373
Bank of New York Mellon
BNY
$103B
$5.03M 0.04%
130,673
+60,798
+87% +$2.59M
APH icon
374
Amphenol
APH
$185B
$5.01M 0.04%
149,690
+82,258
+122% +$2.99M
CM icon
375
Canadian Imperial Bank of Commerce
CM
$106B
$4.99M 0.04%
113,349
-137,687
-55% -$6.71M
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.